JP2016006426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016006426A5 JP2016006426A5 JP2015151999A JP2015151999A JP2016006426A5 JP 2016006426 A5 JP2016006426 A5 JP 2016006426A5 JP 2015151999 A JP2015151999 A JP 2015151999A JP 2015151999 A JP2015151999 A JP 2015151999A JP 2016006426 A5 JP2016006426 A5 JP 2016006426A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- expression
- subject
- degree
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000090 biomarker Substances 0.000 claims 35
- 238000000034 method Methods 0.000 claims 32
- 238000012512 characterization method Methods 0.000 claims 8
- 208000019693 Lung disease Diseases 0.000 claims 7
- 229920001184 polypeptide Polymers 0.000 claims 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 5
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 5
- 239000003550 marker Substances 0.000 claims 4
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims 3
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 3
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims 3
- 102000003896 Myeloperoxidases Human genes 0.000 claims 3
- 108090000235 Myeloperoxidases Proteins 0.000 claims 3
- 230000002159 abnormal effect Effects 0.000 claims 3
- 208000036273 reactive airway disease Diseases 0.000 claims 3
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims 2
- 108010002350 Interleukin-2 Proteins 0.000 claims 2
- 108090000978 Interleukin-4 Proteins 0.000 claims 2
- 102000004388 Interleukin-4 Human genes 0.000 claims 2
- 108010002616 Interleukin-5 Proteins 0.000 claims 2
- 108010002586 Interleukin-7 Proteins 0.000 claims 2
- 108090001007 Interleukin-8 Proteins 0.000 claims 2
- 108010063738 Interleukins Proteins 0.000 claims 2
- 102000015696 Interleukins Human genes 0.000 claims 2
- 102000016267 Leptin Human genes 0.000 claims 2
- 108010092277 Leptin Proteins 0.000 claims 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims 2
- 102000007156 Resistin Human genes 0.000 claims 2
- 108010047909 Resistin Proteins 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 2
- 229940039781 leptin Drugs 0.000 claims 2
- 102000016289 Cell Adhesion Molecules Human genes 0.000 claims 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 claims 1
- 102000000018 Chemokine CCL2 Human genes 0.000 claims 1
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 230000035479 physiological effects, processes and functions Effects 0.000 claims 1
- -1 sICAM-1 Proteins 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/403,369 | 2009-03-12 | ||
| US12/403,369 US8541183B2 (en) | 2007-09-11 | 2009-03-12 | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof |
| US23719809P | 2009-08-26 | 2009-08-26 | |
| US61/237,198 | 2009-08-26 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011554259A Division JP2012520469A (ja) | 2009-03-12 | 2010-03-12 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017224257A Division JP6774925B2 (ja) | 2009-03-12 | 2017-11-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016006426A JP2016006426A (ja) | 2016-01-14 |
| JP2016006426A5 true JP2016006426A5 (cg-RX-API-DMAC10.html) | 2016-03-24 |
| JP6250600B2 JP6250600B2 (ja) | 2017-12-20 |
Family
ID=42729154
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011554259A Pending JP2012520469A (ja) | 2009-03-12 | 2010-03-12 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2015151999A Active JP6250600B2 (ja) | 2009-03-12 | 2015-07-31 | 非小細胞肺癌バイオマーカーを検出する方法 |
| JP2017224257A Active JP6774925B2 (ja) | 2009-03-12 | 2017-11-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット |
| JP2019081332A Pending JP2019158890A (ja) | 2009-03-12 | 2019-04-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2021154089A Pending JP2022000650A (ja) | 2009-03-12 | 2021-09-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2024003857A Withdrawn JP2024024128A (ja) | 2009-03-12 | 2024-01-15 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2025078265A Pending JP2025114736A (ja) | 2009-03-12 | 2025-05-08 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011554259A Pending JP2012520469A (ja) | 2009-03-12 | 2010-03-12 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017224257A Active JP6774925B2 (ja) | 2009-03-12 | 2017-11-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット |
| JP2019081332A Pending JP2019158890A (ja) | 2009-03-12 | 2019-04-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2021154089A Pending JP2022000650A (ja) | 2009-03-12 | 2021-09-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2024003857A Withdrawn JP2024024128A (ja) | 2009-03-12 | 2024-01-15 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2025078265A Pending JP2025114736A (ja) | 2009-03-12 | 2025-05-08 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11474104B2 (cg-RX-API-DMAC10.html) |
| EP (4) | EP2406401A4 (cg-RX-API-DMAC10.html) |
| JP (7) | JP2012520469A (cg-RX-API-DMAC10.html) |
| KR (2) | KR102061441B1 (cg-RX-API-DMAC10.html) |
| CN (4) | CN108181457B (cg-RX-API-DMAC10.html) |
| AU (3) | AU2010223911A1 (cg-RX-API-DMAC10.html) |
| CA (2) | CA3024643C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2703714T3 (cg-RX-API-DMAC10.html) |
| PL (1) | PL3257953T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2010105235A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008231575A1 (en) | 2007-03-27 | 2008-10-02 | Immunovia Ab | Protein signature/markers for the detection of adenocarcinoma |
| EP3825693A1 (en) | 2011-04-29 | 2021-05-26 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| GB201319878D0 (en) * | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
| EP3347720A1 (en) * | 2015-09-09 | 2018-07-18 | Somalogic, Inc. | Methods for developing personalized drug treatment plans and targeted drug development based on proteomic profiles |
| CN108026584B (zh) * | 2015-09-11 | 2021-12-10 | 适体科学株式会社 | 非小细胞肺癌诊断用蛋白质生物标志物组及利用其的非小细胞肺癌诊断方法 |
| US20170131289A1 (en) * | 2015-11-10 | 2017-05-11 | Rensselaer Center for Translational Research, Inc. | Methods of detecting and treating pulmonary hypertension |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN112501140B (zh) * | 2020-12-16 | 2022-03-18 | 熊猫乳品集团股份有限公司 | 一种生物活性多肽yfgsgfaapffivrhqllkk及其制备方法和应用 |
| EP4413372A1 (en) * | 2021-10-07 | 2024-08-14 | SomaLogic Operating Co., Inc. | Lung cancer prediction and uses thereof |
| TWI796010B (zh) * | 2021-11-23 | 2023-03-11 | 國立高雄大學 | 基質金屬蛋白酶-1胜肽拓印導電聚合物及其用途 |
| CN117907508A (zh) * | 2023-12-19 | 2024-04-19 | 查理高特(青岛)健康科技有限公司 | 基于代谢组学的高尿酸血症及尿酸性肾病的风险预测系统 |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2284200T3 (es) | 1997-02-12 | 2007-11-01 | Electrophoretics Limited | Marcadores proteicos para cancer de pulmon y uso de los mismos. |
| US20070092917A1 (en) | 1998-05-01 | 2007-04-26 | Isabelle Guyon | Biomarkers for screening, predicting, and monitoring prostate disease |
| RU2236251C2 (ru) | 1999-02-12 | 2004-09-20 | Дзе Скриппс Рисерч Инститьют | Способы лечения опухолей и метастазов с использованием комбинации антиангиогенной терапии и иммунотерапии |
| PT1157041E (pt) | 1999-03-01 | 2005-10-31 | Genentech Inc | Anticorpos para terapia e diagnostico de cancro |
| FI990888A0 (fi) * | 1999-04-20 | 1999-04-20 | Medix Biochemica Ab Oy | Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi |
| KR20020003384A (ko) * | 1999-04-26 | 2002-01-12 | 써로메드, 인크. | 표현형 및 생물학적 마커 동정 시스템 |
| WO2002004600A2 (en) | 2000-07-12 | 2002-01-17 | Smithkline Beecham Corporation | Novel compounds |
| KR20030094281A (ko) * | 2001-03-12 | 2003-12-11 | 모노젠, 인크. | 세포에 기초한 질병상태의 검출 및 질병상태의 구별 |
| US20030190602A1 (en) | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| WO2002099134A1 (en) | 2001-06-05 | 2002-12-12 | Auckland Uniservices Limited | Methods and compositions for assessment of pulmonary function and disorders |
| US20030134339A1 (en) | 2002-01-14 | 2003-07-17 | Thomas Brown | Proteomics based method for toxicology testing |
| EP1497658A2 (en) | 2002-04-11 | 2005-01-19 | Oxford GlycoSciences (UK) Ltd | Protein involved in cancer |
| JP2006509186A (ja) | 2002-05-10 | 2006-03-16 | イースタン バージニア メディカル スクール | 前立腺癌バイオマーカー |
| AU2003240495A1 (en) * | 2002-06-04 | 2003-12-19 | Incyte Corporation | Diagnostics markers for lung cancer |
| CN1854313B (zh) * | 2002-09-30 | 2010-10-20 | 肿瘤疗法科学股份有限公司 | 非小细胞肺癌的诊断方法 |
| TW200413725A (en) | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
| US20060024692A1 (en) * | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
| EP1596854A4 (en) | 2003-02-14 | 2007-06-06 | Childrens Hosp & Res Ct Oak | TREATMENT OF DISEASES RELATED TO REDUCED STICK OXIDE BIOVERABILITY, INCLUDING INCREASED ARGINASE |
| JP2007537984A (ja) * | 2003-03-04 | 2007-12-27 | ワイス | 喘息または他のアレルギー性もしくは炎症性疾患の診断および治療のための組成物および方法 |
| CN1795187A (zh) * | 2003-03-27 | 2006-06-28 | 兰肯瑙医学研究所 | 新型ido抑制剂及其使用方法 |
| JP2005044330A (ja) | 2003-07-24 | 2005-02-17 | Univ Of California San Diego | 弱仮説生成装置及び方法、学習装置及び方法、検出装置及び方法、表情学習装置及び方法、表情認識装置及び方法、並びにロボット装置 |
| EP2343384A3 (en) * | 2004-03-23 | 2012-01-04 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancer |
| WO2005098445A2 (en) | 2004-03-30 | 2005-10-20 | Eastern Virginia Medical School | Lung cancer biomarkers |
| US20060154276A1 (en) | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| EP1805513A4 (en) * | 2004-10-20 | 2009-06-10 | Onco Detectors International L | MIGRATION HEMMFAKTORIM SERUM AS TUMORMARKER FOR PROSTATE, BLADDER, BREAST, OVARIAL, KIDNEY AND LUNG CARCINOMA |
| WO2006045318A2 (en) * | 2004-10-27 | 2006-05-04 | Aarhus Universitet | Diagnosis and treatment of immune-related diseases |
| WO2006060653A2 (en) | 2004-11-30 | 2006-06-08 | Veridex Llc | Lung cancer prognostics |
| CN1300580C (zh) | 2004-12-31 | 2007-02-14 | 中国人民解放军第306医院 | 检测肝癌血清特征蛋白的质谱模型及其制备方法和应用 |
| GB0508863D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Peptide |
| US20080044420A1 (en) | 2005-05-11 | 2008-02-21 | Heavner George A | Anti-IL-13 antibodies, compositions, methods and uses |
| US20070099239A1 (en) | 2005-06-24 | 2007-05-03 | Raymond Tabibiazar | Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| EP1907582B1 (en) | 2005-07-27 | 2012-01-04 | Oncotherapy Science, Inc. | Ect2 as a therapeutic target for esophageal cancer |
| US7612181B2 (en) * | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| KR20140053410A (ko) * | 2005-08-19 | 2014-05-07 | 아보트 러보러터리즈 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
| WO2007026773A1 (ja) | 2005-08-31 | 2007-03-08 | Kurume University | 医用診断処理装置 |
| EP1941276A1 (de) | 2005-10-29 | 2008-07-09 | Bayer Technology Services GmbH | Verfahren zur bestimmung eines oder mehrerer analyten in komplex zusammengesetzten proben biologischen ursprungs und dessen verwendung |
| US9347945B2 (en) | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
| US20080133141A1 (en) | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
| KR100760518B1 (ko) | 2006-07-18 | 2007-09-20 | 삼성정밀공업 주식회사 | 가구용 도어의 닫힘 충격 완충 장치 |
| US7840505B2 (en) | 2006-11-02 | 2010-11-23 | George Mason Intellectual Properties, Inc. | Classification tool |
| EP2087140A2 (en) * | 2006-11-13 | 2009-08-12 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| US8343491B2 (en) * | 2006-12-18 | 2013-01-01 | The Johns Hopkins University | Anti-HIMF antibodies to treat lung diseases |
| JP5085927B2 (ja) | 2006-12-21 | 2012-11-28 | ウィンテックポリマー株式会社 | 難燃性樹脂組成物 |
| CA2678626A1 (en) * | 2007-02-28 | 2008-09-04 | Novimmune S.A. | Anti-ip-10 antibodies and methods of use thereof |
| US20100088264A1 (en) | 2007-04-05 | 2010-04-08 | Aureon Laboratories Inc. | Systems and methods for treating diagnosing and predicting the occurrence of a medical condition |
| WO2008144034A1 (en) | 2007-05-18 | 2008-11-27 | Duke University | Serum biomarkers for the early detection of lung cancer |
| WO2008157383A1 (en) | 2007-06-15 | 2008-12-24 | Biosite Incorporated | Methods and compositions for diagnosis and/or prognosis of ovarian cancer and lung cancer |
| ES2490165T3 (es) | 2007-09-11 | 2014-09-03 | Cancer Prevention And Cure, Ltd. | Método que facilita el diagnóstico y tratamiento del asma y cáncer de pulmón |
| US8541183B2 (en) * | 2007-09-11 | 2013-09-24 | Cancer Prevention And Cure, Ltd. | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof |
| US7888051B2 (en) * | 2007-09-11 | 2011-02-15 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| JP5159242B2 (ja) | 2007-10-18 | 2013-03-06 | キヤノン株式会社 | 診断支援装置、診断支援装置の制御方法、およびそのプログラム |
| WO2009074276A2 (en) | 2007-12-10 | 2009-06-18 | Roche Diagnostics Gmbh | Marker panel for colorectal cancer |
| SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
| CN102037355A (zh) | 2008-03-04 | 2011-04-27 | 里奇诊断学股份有限公司 | 基于多重生物标记物板块诊断和监测抑郁症 |
| CN101587125B (zh) | 2008-05-21 | 2013-07-24 | 林标扬 | 高表达癌症标记物和低表达组织器官标记物组合试剂盒 |
| HRP20160127T1 (hr) | 2008-09-09 | 2016-03-11 | Somalogic, Inc. | Biomarkeri raka pluä†a i njihove uporabe |
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CN101988059B (zh) | 2009-07-30 | 2014-04-02 | 江苏命码生物科技有限公司 | 胃癌检测标记物及其检测试剂盒和生物芯片 |
| CN103582815A (zh) | 2011-02-24 | 2014-02-12 | 佛米利昂公司 | 用于卵巢癌的生物标志物组、诊断方法和测试试剂盒 |
| EP3825693A1 (en) | 2011-04-29 | 2021-05-26 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| WO2015066564A1 (en) | 2013-10-31 | 2015-05-07 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| WO2015138769A1 (en) | 2014-03-12 | 2015-09-17 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for assessing patients with non-small cell lung cancer |
-
2010
- 2010-03-12 PL PL17179032T patent/PL3257953T3/pl unknown
- 2010-03-12 CN CN201810113758.4A patent/CN108181457B/zh active Active
- 2010-03-12 CA CA3024643A patent/CA3024643C/en active Active
- 2010-03-12 KR KR1020187026414A patent/KR102061441B1/ko active Active
- 2010-03-12 EP EP10751519A patent/EP2406401A4/en not_active Withdrawn
- 2010-03-12 KR KR1020117023448A patent/KR101900016B1/ko active Active
- 2010-03-12 JP JP2011554259A patent/JP2012520469A/ja active Pending
- 2010-03-12 CA CA2755301A patent/CA2755301C/en active Active
- 2010-03-12 CN CN202110251315.3A patent/CN113189342B/zh active Active
- 2010-03-12 WO PCT/US2010/027243 patent/WO2010105235A2/en not_active Ceased
- 2010-03-12 ES ES17179032T patent/ES2703714T3/es active Active
- 2010-03-12 CN CN201410593458.2A patent/CN104535765A/zh active Pending
- 2010-03-12 EP EP17179032.2A patent/EP3257953B1/en active Active
- 2010-03-12 EP EP14182060.5A patent/EP2857522A3/en not_active Withdrawn
- 2010-03-12 CN CN2010800172205A patent/CN102405296A/zh active Pending
- 2010-03-12 EP EP18194795.3A patent/EP3444359B1/en active Active
- 2010-03-12 AU AU2010223911A patent/AU2010223911A1/en not_active Abandoned
-
2015
- 2015-07-31 JP JP2015151999A patent/JP6250600B2/ja active Active
-
2016
- 2016-09-14 AU AU2016228188A patent/AU2016228188B2/en active Active
-
2017
- 2017-11-22 JP JP2017224257A patent/JP6774925B2/ja active Active
-
2018
- 2018-03-23 AU AU2018202110A patent/AU2018202110B2/en active Active
- 2018-03-30 US US15/941,046 patent/US11474104B2/en active Active
-
2019
- 2019-04-22 JP JP2019081332A patent/JP2019158890A/ja active Pending
-
2021
- 2021-09-22 JP JP2021154089A patent/JP2022000650A/ja active Pending
-
2024
- 2024-01-15 JP JP2024003857A patent/JP2024024128A/ja not_active Withdrawn
-
2025
- 2025-05-08 JP JP2025078265A patent/JP2025114736A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liberto et al. | Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review | |
| JP2015514227A5 (cg-RX-API-DMAC10.html) | ||
| ES2703714T3 (es) | Métodos de identificación, evaluación, prevención y terapia de enfermedades pulmonares y kits de los mismos, incluida la identificación, evaluación, prevención y terapia de enfermedades en base al género | |
| Park et al. | Study design and outcomes of Korean obstructive lung disease (KOLD) cohort study | |
| JP2022000650A5 (cg-RX-API-DMAC10.html) | ||
| KR101378919B1 (ko) | 혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커 | |
| JP2010509576A5 (cg-RX-API-DMAC10.html) | ||
| CN114015773B (zh) | 全身炎症反应指数在胃肠道弥漫性大b细胞淋巴瘤预后评估中的应用 | |
| CN113436677A (zh) | 测试受试者患有肝癌可能性的系统及方法 | |
| Losada et al. | Locally-secreted interleukin-6 is related with radiological severity in smear-negative pulmonary tuberculosis | |
| CN119959557A (zh) | 蛋白标志物在制备用于预测受试者未来冠心病发病风险的产品中的应用 | |
| Wei et al. | An effective and affordable blood test for lung cancer early detection using four protein markers and artificial intelligence | |
| Kumari et al. | Analysis of biochemical and inflammatory markers for predicting COVID-19 severity: insights from a Tertiary Healthcare Institution of Eastern India | |
| JP6250351B2 (ja) | 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー | |
| WO2021250267A1 (en) | A method for early detection of propensity to severe clinical manifestations | |
| CN113699235B (zh) | 免疫原性细胞死亡相关基因在头颈鳞癌生存预后及放疗应答性中的应用 | |
| Harsini et al. | Interleukin-6 and neutrophil–Lymphocyte ratio in predicting outcome of confirmed COVID-19 patients | |
| CN116008556A (zh) | MxA作为蛋白标志物的应用及其试剂盒 | |
| Fadhil et al. | Assessment of Serum Neopterin Levels in patients hospitalized with severe COVID-19 | |
| Batmunkh et al. | Some Clinical and Immunological Features of Imported COVID-19 Cases in Mongolia | |
| CN117230194B (zh) | 一种适用于伴发胸腔积液t细胞淋巴瘤患者的预后评估系统及其应用 | |
| Zeng et al. | Thymidine phosphorylase is increased in patients with infection and could be a prognostic marker for sepsis and disseminated intravascular coagulation | |
| CN121299134B (zh) | Kl-6单独及联合其他炎症免疫标志物在复杂性矽肺识别及肺功能损伤评估中的应用 | |
| RU2825710C2 (ru) | Способ прогнозирования летального исхода у пациентов с цитокиновым штормом, ассоциированным с COVID-19 | |
| Kong et al. | Reference intervals for circulating angiogenic cytokines. |